Nordic Bioscience cancer biomarker gets FDA go ahead
Danish biomarker company Nordic Bioscience says its PRO-C3 biomarker assay has received a Letter of Support (LoS) from the U.S. Food and Drug Administration (FDA).
Danish biomarker company Nordic Bioscience says its PRO-C3 biomarker assay has received a Letter of Support (LoS) from the U.S. Food and Drug Administration (FDA).
New data have revealed that 72% of research scientists believe open-source collaboration and workflow management is now “fundamental” to the work they do. The data
Solu, founded in 2022, is a Finnish biotechnology company focusing on combating antibiotic resistance by building the world’s most extensive pathogen DNA library. Solu’s product
IOME Bio, a French seed stage biotechnology company focused on overcoming tumor resistance to immune checkpoint inhibition, has published its foundational research by founders Arlene
All living cells contain proteins with different functions, depending on the type of cell. Researchers at the University of Gothenburg in Sweden have discovered a
Owlstone Medical has announced new data on the development of a screening test for the early detection of lung cancer. The results and research progress
Mithra, a company dedicated to women’s health, has announced new positive data from preclinical studies on inhibitors of CSF-1R in development, in collaboration with BCI
Axol Bioscience Ltd., a pluripotent stem cell technology provider for drug discovery, has signed an agreement with StrataStem to access and commercialize its collection of
CellCentric has announced that the U.S. Food and Drug Administration (FDA) has granted its novel cancer drug, inobrodib, Fast Track designation for the treatment of
Aelis Farma, a clinical-stage biopharmaceutical company focused on developing treatments for brain diseases, has presented new preclinical data on its drug candidate AEF0217 at the